Table 3 Comparison of clinical characteristics of patients with primary fractures with different comorbidities

L1-4BMD (g/cm²)

0.919 ± 0.156

0.906 ± 0.164

0.462

0.915 ± 0.160

0.905 ± 0.165

0.425

0.939 ± 0.148

0.905 ± 0.165

0.054

0.866 ± 0.129

0.910 ± 0.165

0.014*

Total hip BMD (g/cm²)

0.767 ± 0.129

0.755 ± 0.134

0.410

0.744 ± 0.122

0.760 ± 0.137

0.083

0.762 ± 0.114

0.756 ± 0.136

0.621

0.748 ± 0.100

0.757 ± 0.136

0.510

Femoral neck BMD (g/cm²)

0.697 ± 0.118

0.710 ± 0.120

0.754

0.689 ± 0.111

0.704 ± 0.122

0.087

0.713 ± 0.101

0.699 ± 0.121

0.241

0.697 ± 0.088

0.701 ± 0.121

0.767

Serum BGP (ng/mL)

17.732 ± 8.914

21.171 ± 13.710

0.013*

21.111 ± 10.082

20.734 ± 14.161

0.706

24.043 ± 31.639

20.508 ± 9.902

0.297

20.911 ± 6.464

20.814 ± 13.663

0.956

Serum CTX (pg/mL)

466.968 ± 251.334

472.250 ± 249.335

0.839

498.15 ± 286.683

463.893 ± 236.927

0.099

517.143 ± 341.965

467.310 ± 238.352

0.182

463.267 ± 216.814

472.254 ± 251.466

0.785

Serum Ca (mmol/L)

2.266 ± 0.110

2.282 ± 0.123

0.224

2.293 ± 0.125

2.277 ± 0.121

0.080

2.285 ± 0.139

2.280 ± 0.120

0.713

2.301 ± 0.149

2.279 ± 0.120

0.173

Serum P (mmol/L)

1.999 ± 0.201

1.194 ± 0.166

0.783

1.196 ± 0.205

1.194 ± 0.157

0.906

1.171 ± 0.166

1.197 ± 0.170

0.171

1.203 ± 0.186

1.194 ± 0.168

0.670

Serum PTH (pg/mL)

45.342 ± 18.048

46.243 ± 23.672

0.708

47.853 ± 24.717

45.648 ± 22.663

0.205

47.008 ± 27.107

46.068 ± 22.750

0.715

44.073 ± 21.390

46.285 ± 23.267

0.470

Serum 25OHD (nmol/L)

53.178 ± 40.188

54.135 ± 35.525

0.799

54.176 ± 39.733

53.996 ± 34.859

0.947

54.833 ± 36.814

53.960 ± 35.950

0.827

58.642 ± 42.079

53.740 ± 35.588

0.303